The Wild Market Rollercoaster: C.H. Robinson Faces Harsh 12% Plummet as Other Stocks Skyrocket

Avatar photo

C.H. Robinson Worldwide, Inc. stocks took a nosedive in light of a dismal fourth quarter performance, sending investors into a tailspin.

The fourth-quarter revelation saw C.H. Robinson Worldwide’s adjusted earnings plummet to 50 cents per share, marking a significant shortfall from the forecasted 81 cents per share. The company’s quarterly sales were equally disappointing, coming in at $4.20 billion compared to the anticipated $4.34 billion.

The unsettling report caused C.H. Robinson Worldwide shares to plummet by a whopping 12.6% to just $73.49, leaving investors reeling from the unexpected turbulence.

Amidst this tumultuous period, other stocks were flourishing in the mid-day session, skyrocketing and defying all market odds.

Stocks on the Rise

  • Minim, Inc. MINM shares climbed a staggering 57.3% to $6.45 following David E. Lazar’s disclosure of a massive 51% active stake in the company.
  • Clearmind Medicine Inc. CMND surged 51% to $2.17 after announcing a groundbreaking long-term licensing agreement with BIRAD.
  • NeuroBo Pharmaceuticals, Inc. NRBO catapulted 52.9% to $5.00 following the FDA’s clearance of IND for a Phase 1 clinical trial of DA-1726, a revolutionary treatment for obesity.
  • FibroBiologics, Inc. FBLG saw a phenomenal 47.4% increase to $42.90 after announcing its direct listing on the NASDAQ.
  • Celularity Inc. CELU, defying all odds, soared 36% to $0.5191, projecting a robust FY24 net sales outlook of $50 million to $56 million.
  • Cimpress plc CMPR defied market norms by surging 28.8% to $96.90 following a stellar second-quarter financial report and the board’s authorization for the repurchase of up to $150 million of company shares.
  • TuSimple Holdings Inc. TSP rose by an astonishing 28% to $0.2950, driving investors to a state of sheer disbelief.
  • Elevai Labs, Inc. ELAB surged by an astounding 23.5% to $0.84, following an 8% gain a day prior, leaving investors giddy with excitement.
  • Asset Entities Inc. ASST climbed a remarkable 22.8% to $0.5650, proving to be a lucrative opportunity for astute investors.
  • Kiora Pharmaceuticals, Inc. KPRX defied expectations by leaping 20.4% to $0.6649 following the announcement of a private placement of up to $45 million.
  • Evaxion Biotech A/S EVAX gained an impressive 19.5% to $4.70 after announcing the pricing of a $15 million public offering of 3.750 million ADS at $4.00 per ADS, proving to be a bullish investment.
  • Nextracker Inc. NXT climbed 18.8% to $53.79 against all odds after reporting stellar third-quarter financial results, much to the delight of eager investors.
  • SunPower Corporation SPWR, much to everyone’s surprise, jumped 18.1% to $3.5791, validating the company’s financial strategy and management for shareholders.
  • BioRestorative Therapies, Inc. BRTX gained an impressive 16.4% to $1.8850, illustrating a robust financial position and substantial market demand.
  • Corteva, Inc. CTVA defied market predictions by gaining 16.2% to $52.84 following the announcement of better-than-expected quarterly financial results, the issuance of a 2024 guidance, and a plan for a $1 billion repurchase plan, making analysts do a double take.
  • Nextracker Inc. NXT leaped 16.1% to $52.56, utterly surprising investors, after the company reported stellar quarterly financial results, leaving analysts flabbergasted.
  • Yoshiharu Global Co. YOSH rose by 15.9% to $5.10, posing as a Cinderella story amongst the market mayhem.
  • FuelCell Energy, Inc. FCEL gained 15.7% to $1.3885, much to the astonishment of market experts and investors alike, proving to be a dark horse of the session.
  • Plug Power Inc. PLUG climbed 12.2% to $4.9900 after the successful completion of the first customer fill of liquid green hydrogen at its Georgia plant, a result that nobody saw coming.
  • Credit Acceptance Corporation CACC jumped 11.9% to $605.43, leaving analysts and market participants pleasantly surprised following upbeat earnings, a true David and Goliath moment.
  • Digi International Inc. DGII gained 11.7% to $27.17, defying all expectations after delivering strong results, proving that sometimes truth is stranger than fiction.
  • Oragenics, Inc. OGEN gained a remarkable 11.1% to $2.5561 after a steep decline of around 34% on Wednesday, following the company’s recent announcement of the termination of at-market offering program, a phoenix rising from the ashes.
  • Allegro MicroSystems, Inc. ALGM climbed 10.9% to $28.77, in defiance of market gravity, following upbeat earnings, which turned the tables on skeptics.
  • Ferrari N.V. RACE gained 10.4% to $382.17 after reporting fourth-quarter financial results and issuing a 2024 guidance, proving that some stocks are truly built for speed.
  • Etsy, Inc. ETSY rose by 9.6% to $72.95 after the announcement of Elliott Investment Management’s Marc Steinberg’s appointment to its board, signaling a new era of growth for the company.
  • Boot Barn Holdings, Inc. BOOT gained 8.4% to $77.79 following heartening earnings, proving that some boots are just made for walking, right into the investor’s thriving portfolios.
  • Sally Beauty Holdings, Inc. SBH jumped 7.4% to $13.24 after a positive earnings report, much to the delight of its loyal investors.
  • EverQuote, Inc. EVER gained 7.2% to $13.53, proving that a small move forward can sometimes make a big difference for shareholders.




Stock Market Winners and Losers

Deutsche Bank Strikes Gold, While Others Fall Behind

Winners

  • Bank Aktiengesellschaft DB shares gained 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.

Losers

  • Revelation Biosciences, Inc. REVB shares dipped 61.1% to $3.4268 after the company announced pricing of $6.2 million public offering.
  • InVivo Therapeutics Holdings Corp. NVIV fell 49% to $0.3267. InVivo Therapeutics Holdings and subsidiary filed for Chapter 11 bankruptcy in Delaware but plan to continue operating under court supervision as a debtor-in-possession.
  • Hesai Group HSAI declined 28.2% to $4.1817. Hesai Group issued a statement on the U.S. Department of Defense “Chinese Military Companies” list.
  • FibroBiologics, Inc. FBLG fell 27.4% to $21.12.


The free Daily Market Overview 250k traders and investors are reading

Read Now